Examination of mycosis fungoides for the presence of Epstein-Barr virus and human herpesvirus-6 by polymerase chain reaction

Journal of the European Academy of Dermatology and Venereology

Volumn 15, Issue 5, 2001, Pages 422-426

  Erkek, E ^a,b   Sahin, S ^a   Atakan, N ^a   Kocagoz T ^a   Olut, A I ^a   Gokoz A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Cutaneous T cell lymphoma; Epstein Barr virus; Human herpesvirus 6; Mycosis fungoides; Polymerase chain reaction

Indexed keywords

DNA; FORMALDEHYDE; PARAFFIN;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; ETIOLOGY; EVIDENCE BASED MEDICINE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MYCOSIS FUNGOIDES; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; SKIN BIOPSY; SKIN DEFECT; T CELL LYMPHOMA; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CULTURE TECHNIQUES; DNA, VIRAL; FEMALE; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYCOSIS FUNGOIDES; POLYMERASE CHAIN REACTION; REFERENCE VALUES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0034760025     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2001.00309.x     Document Type: Article

References (32)

1. Do environmental factors play any role in the pathogenesis of mycosis fungoides and Sézary syndrome?
2. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions
3. Langerhans cells: Involvement in the pathogenesis of mycosis fungoides
4. Mycosis fungoides in relation to environmental exposures and immune response: A case-control study
5. Mycosis fungoides and Sézary syndrome
6. The thymus bypass model
7. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders
8. Epstein-Barr virus: An etiological factor in cutaneous lymphoproliferative disorders?
9. Detection of human herpes virus-6 in peripheral blood and saliva
10. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sézary syndrome
11. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations
12. Detection of Epstein-Barr virus and HTLV-I in T-cell lymphomas of skin in Taiwan
13. Cutaneous manifestations of Epstein-Barr virus-associated T cell lymphoma
14. Absence of Epstein-Barr viral encoded RNA (EBER) in primary cutaneous T-cell lymphoma
15. Mycosis fungoides: Expression of c-myc p62 p53, bcl-2 and absence of association with Epstein-Barr virus
16. Examination of cutaneous T-cell lymphoma for human herpesviruses by using the polymerase chain reaction
17. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders
18. Phenotypic and cytotoxic characteristics of peripheral T-cell and NK-cell lymphomas in relation to Epstein-Barr virus association
19. Detection of Epstein-Barr virus and human herpesvirus 7 and 8 genomes in primary cutaneous T- and B-cell lymphomas
20. Epstein-Barr virus-oncogen or mitogen?
21. Aggressive cutaneous T-cell lymphoma associated with the presence of Epstein-Barr virus. 2 cases
22. Epstein-Barr virus in a CD8-positive T-cell lymphoma
23. Biology of disease: Defective immune surveillance in viral carcinogenesis
24. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection
25. What's new in human herpesvirus-6? Clinical immunopathology of the HHV-6 infection
26. Human herpesvirus-6 revisited
27. Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases
28. The new herpesviruses. Emerging pathogens of dermatological interest
29. The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: An overview
30. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6
31. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6